Videos
click on the image above to watch the teleconference
(to view the teleconference in fullscreen, click on the bottom right square icon beside the YouTube logo)
Learn about the latest information regarding a robust immune system’s effects on long-term remission by tuning in to…
Videos
click on the image above to watch the teleconference
(to view the teleconference in fullscreen, click on the bottom right square icon beside the YouTube logo)
Living Well with Myeloma Teleconference Series:
Chemo Brain - Is it Real?:
What Myeloma Patients and Caregivers…
Videos
Dr. David Tamborero on the Landscape of Driver Lesions in Multiple Myeloma and Consequences for Targeted Drug Response
Program: Oral and Poster Abstracts
Session: 651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster II
David…
Videos
Jeremy Larsen, MD
Mayo Clinic
Rochester, Minnesota, USA
Free light chain assay and cytogenetic abnormalities for identification of high-risk smoldering myeloma
Abstract No: 8595
Background…
Videos
Gunjan L. Shah, MD
Tufts Medical Center Oncology
Boston Massachusetts, USA
Survival benefit and cost of autologous hematopoietic stem cell transplantation (Auto HSCT) in elderly patients with multiple myeloma (MM) using the SEER-Medicare database
Background: Medicare…
ASCO 2014: Continuous treatment versus fixed duration of therapy in newly diagnosed myeloma patients
Videos
Antonio Palumbo, MD
University of Torino
Torino Italy
Continuous treatment (CT) versus fixed duration of therapy (FDT) in newly diagnosed myeloma patients: PFS1, PFS2, OS endpoints
Abstract No: 8515
Background: Continuous therapy significantly…
Videos
Keith K. Stewart, MB ChBMayo ClinicScottsdale, Arizona, USAE1A06: A phase III trial comparing melphalan, prednisone, and thalidomide (MPT) versus melphalan, prednisone, and lenalidomide (MPR) in newly diagnosed multiple myeloma (MM)Abstract No: 8511Background: …
Audio
Laura and Charlie Mooney are the leaders of the 20-member Staten Island Support Group in New York. The pair became Support Group leaders in 2013, following Charlie’s 2010 myeloma diagnosis.
Audio
Monica and Godfrey Taylor are the leaders of the Kingston, Jamaica Support Group, which they founded with the IMF’s help back in 2013. This pair wanted to establish a Myeloma Support Group to help others living with the disease after Monica’s 2011 myeloma diagnosis.
Audio
Delray Beach, FL
Allan and Gail met on a blind date on a cold wintery December night in 1961. Allan was home from Long Island on a Christmas break from his work at Sperry Gyroscope. They both had attended the University of Pittsburgh, but Allan was three years ahead of Gail, and they had…
Audio
In Memorium: Unfortunately, Elverta Mock Harris passed away on August 13, 2019. She and her late husband Harold shared the story of her myeloma journey here.
Elverta Mock is a Licensed Clinical Social Worker and retired Correctional Administrator.
In 2012, Elverta was diagnosed with myeloma,…
Audio
Doug Young
Ashland, VA
Doug was born in 1948 and diagnosed with multiple myeloma in February 2012. He had stem cell transplant at VCU in 2013 and retired from UPS shortly after. Prior to that he worked as V.P. of Operations for a trucking company and as college professor at Liberty University.…
Videos
In this week's video, Dr. Brian Durie answers the question regarding statins and its effect on myeloma patients.Bottom Line:Myeloma patients need to be cautious when taking statins...But not overly concerned about their impact on the myeloma itself.
Audio
Jack and Linda Huguelet are the leaders of the Chattanooga, Tennessee Support Group. They have been leading the 10-member group since 2011, following Linda’s 2010 myeloma diagnosis.
Audio
Jim Shoemaker was diagnosed with myeloma in 2007. In 2013, he and his wife Linda began their leadership of the Memphis, Tennessee support group. Together they lead a group averaging anywhere from 12 to 20 members.
Audio
Joe and Sandy Brown became active members of the myeloma community after Sandy’s myeloma diagnosis 25 years ago. Together they’ve been involved in the Atlanta, Georgia Support Group for more than 15 years and have been co-leaders of the nearly 40-member group since 2011. Sandy is also on the Group…
News Article
This was a busy week in the world of cancer research!
Amgen announced promising follow-up results from the ASPIRE trial in which KRd (Kyprolis®, Revlimid® and dexamethasone) has produced a median overall survival of 48.3 months versus Rd’s 40.4 months for patients in the first relapse…
News Article
THOUSAND OAKS, Calif. (July 24, 2015) – Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for Kyprolis® (carfilzomib) for Injection in combination with Revlimid® (lenalidomide) and dexamethasone (KRd) for the…
Videos
In this week's video Dr. Brian G.M. Durie answers Laura Mooney's question about amyloidosis and if myeloma patients should be screened for it.
Bottom Line:
Keep amyloidosis testing on your doctor's checklist.
News Article
NORTH HOLLYWOOD, Calif., July 22, 2015 – The International Myeloma Foundation (IMF) – improving the quality of life of myeloma patients while working toward prevention and a cure – today announced publication of a new updated edition of Multiple Myeloma: A Textbook…
Videos
In this week's video, Dr. Brian G.M.Durie answers a question if the symptoms of Vitamin B12 deficiency is an effect of multiple myeloma treatment.
BOTTOM LINE:
Look for other issues that could be causing symptoms that might be easily corrected…
Videos
In this week's video, Dr. Brian G.M. Durie answers a question on how common toxoplasmosis is and how multiple myeloma patients can protect themselves.
News Article
WASHINGTON, D.C. June 12, 2015 – The International Myeloma Foundation (IMF) – improving the quality of life of myeloma patients while working toward prevention and a cure – applauds the introduction today of legislation by Senators Al Franken (D-MN) and Mark Kirk (R-IL),…
Videos
In this week's video, Dr. Brian G.M. Durie discusses the practical details of Fluorescence In Situ Hybridization (FISH) testing.
News Article
The International Myeloma Foundation (IMF) presented the 14th annual Robert A. Kyle Lifetime Achievement Award to Dr. S. Vincent Rajkumar during a ceremony in Copenhagen, Denmark on Wednesday evening, June 8, 2016. The award was given during the IMF’s annual…
News Article
The International Myeloma Foundation (IMF) and Xian-Janssen (XJP) cooperate in a program of joint activities to strengthen the capacity of Chinese hematologists working in the field of myeloma.
As part of this cooperation, IMF briefing sessions featuring internationally renowned…
News Article
North Hollywood, CA, June 3, 2015 – The International Myeloma Foundation (IMF) – improving the quality of life of myeloma patients while working toward prevention and a cure – will host the 6th Annual International Myeloma Working Group (IMWG) Summit June 8-10 in Vienna,…
Videos
In this week's video, Dr. Brian G.M. Durie answers the question "Are veterans with myeloma a unique population?" Dr. Durie also talked about the challenges that veterans face to get the best care available to them. For more information about veterans with myeloma you can visit: www.veterans.myeloma…
Videos
In this week's video, Dr. Brian G.M. Durie discusses how does myeloma affect the immune system and what can be done for the immune system to work better.
Videos
In this week's #AskDrDurie video, IMF Chairman Dr. Brian Durie discusses how intravenous immunoglobulin is being used as a treatment option for multiple myeloma.
Videos
In this episode of #AskDrDurie, IMF Chairman Dr. Brian G.M. Durie discusses the risks that can come with chiropractic care for patients with myeloma. He also offers some alternative therapeutic options for those who need them.
News Article
Los Angeles, CA - (April 29, 2015) - It is with great sadness that the International Myeloma Foundation (IMF) announces the death of Michael S. Katz, a longtime member of its Board of Directors.
"We are deeply saddened by the passing of Mike Katz," said Susie Novis, IMF…
Audio
Ray grew up in Morgantown, WV and went into the family automobile business after college and the Navy. He then worked for Xerox for several years and ended up buying some investment properties. He still has most of them today! During his free time, Ray enjoys doing volunteer work with the local…
Audio
When Katherine Morgan was diagnosed with myeloma in 2008, her biggest concern was if she would be able to continue with her life as she knew it. Photography was her passion, and she was also concerned about being around her beautiful children and grandchildren, who always have runny noses, etc…
Videos
In this week’s #AskDrDurie, IMF Chairman Dr. Brian G.M.Durie takes a question from a patient who has both myeloma and bipolar disorder. She wants to know what treatment options she has for myeloma, given that she is on medication to treat her bipolar disorder, as well. Dr. Durie offers his advice,…
News Article
North Hollywood, CA, March 31, 2015 – The International Myeloma Foundation (IMF) – improving the quality of life of myeloma patients while working toward prevention and a cure – is proud to announce another successful “Myeloma Awareness Month” (#MAM) during March 2015.
The…
News Article
North Hollywood, CA, March 27, 2015 – The International Myeloma Foundation (IMF) – improving the quality of life of myeloma patients while working toward prevention and a cure – today commended Representative Brian Higgins (D-NY) for introducing a federal resolution (H. Res.…
Videos
In this week’s episode of #AskDrDurie, IMF Chairman Dr. Brian G.M. Durie looks at the factors of myeloma that affect the choice of treatment, including the type of myeloma and any chromosome abnormalities, as well as genetic testing done on the patient.
Videos
In this episode of the IMF's weekly web series, #AskDrDurie, IMF Chairman Dr. Brian G.M. Durie discusses his recommendation for use of the antibiotic Biaxin for patients with myeloma.
This week’s #AskDrDurie is about the antibiotic Biaxin. The patient is anxious to know, ‘What is the…
Videos
In this episode of #AskDrDurie, IMF Chairman Dr. Brian G.M. Durie discusses treatment options available for those myeloma patients with the t(4;14) abnormality, including IMiDs, next-generation proteasome inhibitors, novel combination therapies, and autologous stem cell transplants.
DR. DURIE:…
Videos
In this episode of the IMF’s weekly web series, #AskDrDurie, IMF Chairman Dr. Brian G.M. Durie explains what dysplasia means when it shows up on a bone marrow report.
Transcript
DR. DURIE: This week’s #AskDrDurie question is about the bone marrow report, and the patient asks, ‘What does it…
Videos
In this episode of #AskDrDurie, IMF Chairman Dr. Brian G.M. Durie discusses the use of gadolinium in MRI testing, specifically for patients with abnormal kidney function.
Videos
In this week's episode of #AskDrDurie, IMF Chairman Dr. Brian G.M. Durie answers a patient's question about levels of bone density and how they connect to myeloma.
News Article
Q. How are the drugs approved in 2015 used in treatment?
A. In approving Farydak® (panobinostat), Darzalex® (daratumumab), Ninlaro® (ixazomib), and Empliciti® (elotuzumab) in 2015, the US Food and Drug Administration (FDA) broke with precedent and…
News Article
North Hollywood, CA, November 5, 2015 – The International Myeloma Foundation (IMF) – improving the quality of life of myeloma patients while working toward prevention and a cure – is thrilled to announce that this NBA season the organization’s research and education programs…
Videos
Register NOW for the FREE IMF Virtual Myeloma Community Workshop November 16, 20263:00 PM PT / 4:00 PM MT5:00 PM CT / 6:00PM ET